Document Detail

Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.
MedLine Citation:
PMID:  23199319     Owner:  NLM     Status:  MEDLINE    
Mucosal administration of an antigen eliciting bystander suppression at the site of inflammation results in effective antigen-specific immunotherapy for autoimmune diseases. Heat shock proteins are bystander antigens that are effective in peptide-specific immunotherapy in both experimental and human autoimmune disease. The efficacy of preventive peptide immunotherapy is increased by enhancing peptide-specific immune responses with proinflammatory agents. Combining peptide-specific immunotherapy with general suppression of inflammation may improve its therapeutic effect.
E Zonneveld-Huijssoon; S Albani; B J Prakken; F van Wijk
Related Documents :
24993159 - Resolution of inflammation: targeting gpcrs that interact with lipids and peptides.
646789 - Characterization of the keratan sulphate proteoglycans from bovine corneal stroma.
9922239 - Assembly of the k40 antigen in escherichia coli: identification of a novel enzyme respo...
1394319 - Structure of the exopolysaccharide produced by lactococcus lactis subspecies cremoris h...
7585719 - Structure of the capsular polysaccharide from alteromonas sp. cmm 155.
2243109 - Identification of the keratan sulfate attachment sites on bovine fibromodulin.
11118309 - Amino acid residues conferring herbicide tolerance in tobacco acetolactate synthase.
2144289 - Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoact...
22639449 - Cellular uptakes, biostabilities and anti-mir-210 activities of chiral arginine-pnas in...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  171     ISSN:  1365-2249     ISO Abbreviation:  Clin. Exp. Immunol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-03     Completed Date:  2013-02-19     Revised Date:  2014-01-10    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  20-9     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adaptive Immunity
Antigens / therapeutic use*
Autoimmune Diseases / immunology,  therapy*
Bystander Effect / immunology*
Heat-Shock Proteins / immunology*
Immune Tolerance / immunology
Immunity, Innate
Immunologic Factors / immunology,  therapeutic use
Peptides / immunology,  therapeutic use*
Reg. No./Substance:
0/Antigens; 0/Heat-Shock Proteins; 0/Immunologic Factors; 0/Peptides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
Next Document:  The role of stromal cells in the persistence of chronic inflammation.